
Carolyn Rafieymehr / Wikimedia Commons / Public domain
Clinical Trials/August 15, 2026/3 min read
Recruiting Type 1 diabetes trials watch: what changed in the current registry feed
A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.
clinical trialsClinicalTrials.govT1Dtrial matching
What this is and is not
This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.
A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?
Recruiting records to inspect
- Food Insecurity Reduction & Strategy Team — RECRUITING, NA. Interventions: Nutrition program. Locations: Palo Alto, California, United States. This study seeks to address the multifaceted challenges posed by food disparities and their negative consequences on hea...Source
- Exercise and the Menstrual Cycle in Type 1 Diabetes — RECRUITING, NA. Interventions: Luteal Phase Aerobic Exercise, Follicular Phase Aerobic Exercise. Locations: Edmonton, Alberta, Canada. Female participants with type 1 diabetes using oral contraceptives will be asked to...Source
- A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity — RECRUITING, PHASE1. Interventions: NNC0497-0040, Placebo. Locations: Neuss, Germany. The purpose of this clinical study is to find out if NNC0497-0040 is safe, tolerable and effective for healthy people living with norm...Source
- Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature — RECRUITING, NA. Interventions: Continuous Glucose Monitoring System. Locations: Escondido, California, United States. A prospective, multicenter evaluation of performance and safety of the Eversense Gemini System with f...Source
- Characterization of Type 1 Diabetes Subgroup: An Artificial Intelligence Analysis of Clinical and Glucometric Features — RECRUITING. Locations: Barcelona, Barcelona, Spain. The goal of this observational study is to characterize different subgroups among patients with type 1 diabetes. The main research question is: Are there distinct subt...Source
- The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade Inflammation — RECRUITING, PHASE2. Interventions: Colchicin 0.5 mg once daily for two weeks, then twice daily for two weeks, Placebo once daily for two weeks, then twice daily for two weeks, Colchicine tablet 0.5 mg once-daily for two...Source
- Vey Low-Energy Ketogenic Therapy in Adults With Type 1 Diabetes and Obesity on Intensive Insulin Therapy Using Advanded Hybrid Closed Loop System — RECRUITING, NA. Interventions: VLEKT. Locations: Bari, Italy, Italy. Overweight and obesity are frequent in adults with type 1 diabetes (T1D), with prevalence exceeding 50% in recent studies. Excess weight in T1D is ass...Source
- Glycemic Improvement With Team, Technology, Education and Peer Resources in Type 1 Diabetes-GLITTER Study — RECRUITING, NA. Interventions: GLITTER comprehensive management. Locations: Beijing, Beijing Municipality, China | Beijing, Beijing Municipality, China | Guangzhou, Guangdong, China. The GLITTER study is comprised of fo...Source
Questions before contacting a study
- Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?
- What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?
- Can the family discuss the official record with their endocrinology team before sharing additional personal health details?
This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.